Based on visual inspection and relative levels of expression versus depth of response, preliminary baseline tumor data showed a potential association of higher gene expression of BTK, ITK, and BMX with patients who had a treatment response, CR, PR, or stable disease versus patients with PD (Figure 3), though this trend was not significant. The gene discussed is BTK; the disease is neoplasm.